Dual azithromycin/ceftriaxone therapy for gonorrhea in PrEP cohorts results in levels of macrolide consumption that exceed resistance thresholds by up to 7-fold

Chris Kenyon

doi:10.1093/infdis/jiab178

Dual azithromycin/ceftriaxone therapy for gonorrhea in PrEP cohorts results in levels of macrolide consumption that exceed resistance thresholds by up to 7-fold

Chris Kenyon

Sexually Transmitted Infections

Research output: Contribution to journal › Letter › peer-review

10 Downloads (Pure)

Original language	English
Journal	Journal of Infectious Diseases
Volume	224
Issue number	9
Pages (from-to)	1623-1624
Number of pages	2
ISSN	0022-1899
DOIs	https://doi.org/10.1093/infdis/jiab178
Publication status	Published - 2021

Access to Document

10.1093/infdis/jiab178Licence: Other

2021jidi1623Final published version, 143 KBLicence: Other

Cite this

@article{54933e64b71e4b249f3b7daf04541d5e,

title = "Dual azithromycin/ceftriaxone therapy for gonorrhea in PrEP cohorts results in levels of macrolide consumption that exceed resistance thresholds by up to 7-fold",

author = "Chris Kenyon",

note = "FTX; NOOA",

year = "2021",

doi = "10.1093/infdis/jiab178",

language = "English",

volume = "224",

pages = "1623--1624",

journal = "Journal of Infectious Diseases",

issn = "0022-1899",

publisher = "Oxford University Press",

number = "9",

}

TY - JOUR

T1 - Dual azithromycin/ceftriaxone therapy for gonorrhea in PrEP cohorts results in levels of macrolide consumption that exceed resistance thresholds by up to 7-fold

AU - Kenyon, Chris

N1 - FTX; NOOA

PY - 2021

Y1 - 2021

U2 - 10.1093/infdis/jiab178

DO - 10.1093/infdis/jiab178

M3 - Letter

C2 - 33822092

SN - 0022-1899

VL - 224

SP - 1623

EP - 1624

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

IS - 9

ER -